HOME >> BIOLOGY >> NEWS
New science investigations, a fresh team ready for Expedition Three on International Space Station

cks will continue to support existing and new experiments.

"We are doing science in all the disciplines, and the science is becoming more complex with every new expedition," said Uri. "With Expedition Three, we are pleased to bring a number of new scientists to the Space Station team, and look forward to continuing work with those who already have experiments on our newest orbital research facility."

Eight new experiments will get under way in the five research facilities, and 10 experiments -- started on Expedition One or Two -- will continue.

"One of the advantages of Space Station research is the flexibility to continue long-duration research over several expeditions, modifying research procedures and parameters to take advantage of intriguing results," said Uri. "We want science on the Station to be as much like science in an Earth-based laboratory as possible, but of course without gravity."

The first experiment to be mounted outside the Station -- the Materials International Space Station Experiment (MISSE) - will be delivered by the STS-105 crew and mounted outside the Station during an Extravehicular Activity, or space walk. MISSE will test the durability of hundreds of samples, ranging from lubricants to solar cell technologies.

By examining how coatings fare in the harsh environment of space, scientists can learn how to develop materials for future spacecraft and make materials last longer on Earth. Rachel Kamenetzky is the MISSE principal investigator at the Marshall Center, and the experiment is managed by Langley Research Center in Hampton, Va., and is a collaborative effort among NASA centers, the U.S. Air Force and private industry.

The first experiments with biological cell cultures also begin on the Station in Expedition Three, with delivery of a major facility: the Cellular Biotechnology Operations Support System (CBOSS).

"This will be our first opportunity to use a sophisticated bioreactor t
'"/>

Contact: Steve Roy
steve.roy@msfc.nasa.gov
256-544-0034
NASA/Marshall Space Flight Center News Center
8-Aug-2001


Page: 1 2 3 4

Related biology news :

1. Student science contest participation influences study, career choices, alumni say
2. Houston minority graduation rises in sciences, engineering as result of UH-led alliance
3. New Arizona State center brings science to policy on issues of water resources and urban growth
4. 4 October press briefing to focus on minority recruitment to science and engineering programs
5. Agronomy, crop, and soil science societies to meet Oct. 31 to Nov. 4 in Seattle
6. News tips from the Journal of Neuroscience
7. Former US Secretary of the Interior Bruce Babbitt to speak at science symposium
8. News tips from the Journal of Neuroscience
9. Discoveries in neuroscience
10. News tips from the Journal of Neuroscience
11. MSU group reviews Berkeley venture into brave new science funding world

Post Your Comments:
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:7/2/2015)... 2015 Research and ... the "Natural Language Processing Market by Type ... Pattern & Image Recognition) - Worldwide Forecast to ... The key vendors occupying the market are 3M, ... Corporation, NetBase Solutions, SAS Institute Inc., Verint Systems ...
(Date:7/2/2015)... GOTHENBURG, Sweden , July 2, 2015 ... fingerprint sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor ... is one of FPC,s distributors in Asia ... Q4 2015. The sensors will be used by smartphone manufacturers ... 268 MSEK is included in the communicated revenue guidance of ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
(Date:7/30/2015)... ... , ... Ralco is honored to announce that it is the primary sponsor ... August 5-9 in Marshall. The Ralco Enrichment Center is an interactive experience where the ... their daily lives. This unique exhibit also features a birthing center for fair goers ...
(Date:7/30/2015)... July 30, 2015 According to ... (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, ... Preclinical, Clinical Trial), by End Users - Global Forecast ... expected to reach USD 2,107.99 million by 2020 from ... 15.29%. Browse more than ...
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
Cached News: